Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026)
Alvotech's (ALVO) quarterly Non-Current Deferred Tax Liability came in at $6.9 million in Q2 2026, up 242.7% on a YoY basis from $2.0 million in Q2 2025, and down 3.66% quarter-over-quarter from $7.2 million in Q1 2026.
Analysis
Alvotech (ALVO) Non-Current Deferred Tax Liability (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Non-Current Deferred Tax Liability for 7 consecutive years, with $6.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 242.7% year-over-year to $6.9 million; the trailing twelve-month figure through Jun 2026 stood at $6.9 million (up 242.7% YoY), and the FY2025 full-year result was $7.9 million, up 334.46% from the prior year.
- Non-Current Deferred Tax Liability retreated to $6.9 million in Q2 2026 per ALVO's latest filing, from $7.2 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $7.9 million in Q4 2025 and bottomed at $45000.0 in Q2 2023.
- Historically, Non-Current Deferred Tax Liability has averaged $2.9 million across 5 years, with a median of $1.7 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability sank 82.85% in 2023, then jumped 3316.98% in 2024.
- Over 5 years, Non-Current Deferred Tax Liability stood at $309000.0 in 2022, then tumbled by 82.85% to $53000.0 in 2023, then surged by 3316.98% to $1.8 million in 2024, then surged by 334.46% to $7.9 million in 2025, then dropped by 12.28% to $6.9 million in 2026.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $6.9 million, $7.2 million, and $7.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.90 Mn |
| Mar 31, 2026 | 7.16 Mn |
| Dec 31, 2025 | 7.87 Mn |
| Sep 30, 2025 | 7.54 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 1.81 Mn |
| Sep 30, 2024 | 1.54 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 53,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Dec 31, 2022 | 309,000.00 |
| Jun 30, 2022 | 141,000.00 |
| Dec 31, 2021 | 150,000.00 |
| Dec 31, 2020 | 217,000.00 |